Initiated registrational Phase 2b SAFEGUARD trial of SAB-142 in new-onset, Stage 3 autoimmune T1D patientsMultiple SAFEGUARD ...
Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarter ended September 30, 2025.
S&P 500, Northrop Grumman Corporation, Lockheed Martin Corporation, iShares Russell 2000 ETF. Read 's Market Analysis on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback